Project Grant R01AI197356
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California, Davis a $404,570 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 13, 2026, with a completion date of January 31, 2028. The award funds research to identify and validate target antigens recognized by protective Chlamydia-specific memory CD4 T cells that provide immunity to the female reproductive tract. The...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $431,750 Project Grant to the University of California, Irvine under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period August 1, 2025 through July 31, 2027. The research project focuses on developing and validating new complementation tools and conditional expression methods to enhance genetic approaches for studying Chlamydia trachomatis virulence determinants....
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $492,000 to The Regents of the University of California, San Francisco under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 1, 2025, for a five-year project period concluding July 31, 2030. The award funds biochemical and structural characterization research of the elongasome and divisome protein complexes in Mycobacterium tuberculosis (MTB) and the...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $126,460 Project Grant to the University of California, Davis on August 21, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports investigator-initiated research aimed at identifying ecological drivers of dysbiosis in the female reproductive tract (FRT), with performance extending through July 31, 2027. The research will employ genetically...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Virginia a Project Grant of $450,766 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 8, 2025, with completion targeted for July 31, 2027. This research initiative aims to characterize how Chlamydia trachomatis, the leading cause of bacterial sexually transmitted infections, remodels inter-organelle communication within host cells to create a...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Regents of the University of California, San Francisco $150,104 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on January 12, 2026, for a two-year project period concluding January 11, 2028. This Project Grant supports investigator-initiated biomedical research addressing infectious diseases through fundamental scientific inquiry and methodological...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $787,837 to The Regents of the University of California, San Francisco on April 10, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and apply computational tools for assessing disease transmission risk. The project, which extends through March 31, 2031, focuses on advancing analytical methods to quantify and mitigate the risk of infectious...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California, San Francisco (UCSF) a Project Grant of $694,883 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 15, 2025, with a completion date of August 31, 2030. This award funds research to develop and validate a point-of-care urine Tenofovir (TFV) assay as a triage tool for identifying HIV drug resistance in people living with HIV who are...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Virginia a Project Grant of $717,952 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 9, 2026, with a completion date of January 31, 2031. The grant supports biomedical research investigating host lipid acquisition and the maintenance of the Chlamydia replicative niche. The research focuses on identifying and characterizing essential...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Regents of the University of California, San Francisco a Project Grant of $819,603 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 21, 2025, with a completion date of July 31, 2030. This research initiative, titled "INSIDE START: Implementation of Novel Strategies for Long-Acting ART," addresses the disproportionate impact of HIV on...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded $816,421 to the University of California, San Francisco through its Allergy and Infectious Diseases Research program (CFDA 93.855) on April 6, 2026, for a project spanning approximately five years through March 31, 2031. This Project Grant funds investigator-initiated biomedical research examining the interplay between heterosexual male-female partner microbiomes, Chlamydia trachomatis (CT) infection, and sexual transmission dynamics. The research addresses a significant public health gap by focusing on understudied urethral CT infections in men who have sex exclusively with women (MSW) and transmission patterns to female partners, a population segment not currently covered by Centers for Disease Control screening recommendations. The research deliverables include characterization of male urethral and female endocervical, vaginal, and rectal microbiomes through metagenome shotgun sequencing analysis, quantification of host immune responses through protein assays, and investigation of CT infection pathogenesis mechanisms across these anatomical sites in a large male-female partner cohort with high CT prevalence. By elucidating how microbial communities and immune responses interact with CT infection and transmission, this research is intended to advance scientific knowledge regarding sexually transmitted infection dynamics and ultimately improve prevention and treatment strategies for this leading bacterial STI globally.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $816.4k | 4/6/26 |